WVE
Wave Life Sciences Ltd.
Halal Rating :
Last Price
$10.98
Last updated:
Market Cap
-
7D Change
-2.57%
1 Year Change
134.12%
Company Overview
Industries
Exchange
Next Earnings Date
Wave Life Sciences Ltd. is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. The company focuses on developing novel nucleic acid therapeutics that target genetic drivers of disease, particularly using their proprietary PRISM platform. Their primary business activities involve research and development of treatments for rare diseases, neurological disorders, and other genetic conditions.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $-7676000.0 | $56.24m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $19.69m | $54.69m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $12.54m | $47.0m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Wave Life Sciences Ltd.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.